Rivkin Anna has filed 3 insider transactions across 1 company since September 2024.
Most recent transaction: a grant/award of 165000 shares of Foghorn Therapeutics Inc. ($FHTX) on January 30, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 30, 2026 | Foghorn Therapeutics Inc. | $FHTX | Rivkin Anna | Chief Business Officer | A | Stock option (right to buy) | 165000 | $5.71 | 165,000.0000 | 63,029,293 | 9999.99% | 0.26% |
| Jan. 22, 2025 | Foghorn Therapeutics Inc. | $FHTX | Rivkin Anna | Chief Business Officer | A | Stock Option (right to buy) | 50000 | $4.37 | 50,000.0000 | 54,899,432 | 9999.99% | 0.09% |
| Sept. 3, 2024 | Foghorn Therapeutics Inc. | $FHTX | Rivkin Anna | Chief Business Officer | A | Stock Options (Right to buy) | 190000 | $7.85 | 190,000.0000 | 41,974,484 | 9999.99% | 0.45% |